Ankur P. Choubey

HPB Research Scholar @MSKCancerCenter | @RWJsurgery resident | @UToledoMed and @CWRU Alumnus | Baseball and Canine Enthusiast

[Syed A. Ahmad @SyedAAhmad5]

The problem with new and unregulated technology is that people start doing things with no evidence. 12% of cohort had liver met from pancreas. 11% 30 day mortality. What are we doing?? Biology did not all of a sudden go away.
👇🏼👇🏼
@jamasurgery https://t.co/zaXpwcpnMs

[The New Yorker @NewYorker]

“I was neither angry nor scared. It simply was. It was a fact about the world, like the distance from the sun to the Earth.” Revisit an excerpt from Paul Kalanithi’s posthumously published memoir about his battle with metastatic lung cancer, “When Breath Becomes Air”: https://t.co/GhgW1vcRFm

[Syed A. Ahmad @SyedAAhmad5]

Neoadjuvant Chemotherapy With Gemcitabine and S-1 Versus Upfront Surgery for Resectable Pancreatic Cancer
Results of the Randomized Phase II/III Prep-02/JSAP05 Trial @AnnalsofSurgery

https://t.co/8weh6TPqOw

[Dr. Nina Niu Sanford @NiuSanford]

Wow, many issues w this 47-pt, sponsor-run, single-arm histotripsy study.

Short 🧵 1/4

1. Post-hoc imaging re-read: primary read w validated criteria showed 1-yr LC 63%, but they emphasize a post-hoc re-read (using new “experience” w histo imaging) bumping local control to 90%.

[Syed A. Ahmad @SyedAAhmad5]

PUMP 2 trial now published. Congrats ⁦@BasGrootKoerkam⁩

Hepatic Arterial Infusion Pump Chemotherapy in Patients With Unresectable Intrahepatic Cholangiocarcinoma—PUMP-2 ⁦@JCO_ASCO⁩ ⁦@GregWilson152⁩ ⁦@IHPBA⁩ https://t.co/uSvGM5ap6p

[Julius Chapiro @JuliusChapiro]

Courageous and great article from @MSKCancerCenter on Histotripsy published in @cvironco ! Link: https://t.co/ubMPOeRioK

“Patients arrive with predetermined expectations shaped by marketing rather than clinical reality, pressuring physicians
to offer treatments lacking comprehensive validation. Healthcare institutions acquire expensive systems to
remain competitive, even when clinical need may not justify the investment. Resources are diverted toward technologies with limited proven benefit, while established treatments receive diminished attention.”

“Aggressive promotion, driven by commercial interests and capital market pressures, presents theoretical benefits as established advantages. Current histotripsy studies remain predominantly single-center experiences with
limited follow-up. The technology’s purported immunologic effects remain entirely theoretical, yet marketing
materials present these claims with inappropriate certainty. Patients seek "non-invasive" treatments based on promotional materials overstating capabilities while minimising limitations. This marketing-first approach raises
ethical concerns about informed consent and resource allocation.”

[American College of Surgeons @AmCollSurgeons]

Researchers at @MSKCancerCenter examined longitudinal scans from patients under surveillance for intraductal papillary mucinous neoplasms.

Learn more about their study, which used large language models (LLMs), in @acsJACS ⬇️ https://t.co/vaLk5VjqZB

[Ankur P. Choubey @AnkurPChoubey]

Delighted to see our work on IPMN risk assessment featured in @acsJACS. Highlighting that cyst size alone is not an indicator of malignancy

[Journal of the American College of Surgeons (JACS) @acsJACS]

Pancreatic cyst diameter alone is not strongly predictive of dysplasia and can be safely monitored with low rate of progression during surveillance.

https://t.co/8qh7wm9rwz

[Annals of Surgical Oncology @AnnSurgOncol]

August Issue: Combined Portal and #HepaticVeinEmbolization Produces Greater Hypertrophy than #PortalVeinEmbolization Alone with Similar Post- #Hepatectomy Outcomes and is not Impacted by Hepatic Artery Infusion Chemotherapy @AnkurPChoubey

https://t.co/OWTN2CJjDz

@SyedAAhmad5

[U of T Department of Surgery @UofTSurgery]

The @UofTSurgery community mourns the loss of cherished colleague, Dr. Sean Cleary. "Sean has touched the lives of many of us – as a clinical colleague, teacher, mentor, supervisor, confidential advisor, and friend. . ."
Read the Chair's message at https://t.co/oS8FnBkV9C

[Deshka Foster, MD, PhD @DrDrFoster]

Team #NotoriousHPB having a (very sweaty) blast and raised nearly $30,000 for cancer research at #cycleforsurvival @MSKCancerCenter @Equinox

[Nell Maloney Patel @MaloneyNell]

Congratulations to @rwjsurgery resident @AJRossiMD on your match @OschnerHealth for Colon and Rectal Surgery!🎉 #rutgersresidentsrock @RWJMS

[Ankur P. Choubey @AnkurPChoubey]

Excited to share our work describing trends in pancreatectomy for IPMN with improvement in rates of POPF and increased robotic utilization.

[Catherine Davis, MD @CDavisMD]

Check out our newly published manuscript on trends in the management of #IPMN in @hpbjournal https://t.co/apGmAR1BfI @HenryPittMD @RCLanganMD @RichardalexMD

[Arvin Dar @DarArvin]

How can you selectively block an oncogenic transcription factor? We found that reactivating the epigenetic repressor ezh2 does the job against mutant b-catenin. Mechanism uncovered with a new KI that we developed and named WNTinib.  Check out the paper @NatureCancer

[Catherine Davis, MD @CDavisMD]

#Pancreatoduodenectomy: resection of #pancreas and #duodenum ✅✅✅
#Pancreaticoduodenectomy: resection of #pancreatic duct and duodenum ❌❌❌
#pancreaticcancer #surgtwitter

What is in a word: Pancreatoduodenectomy or pancreaticoduodenectomy? - Surgery https://t.co/I2L9gMNEAM

[Ankur P. Choubey @AnkurPChoubey]

Pleased to share another publication in our series examining the diversity and leadership in #surgery Published in the @SESC_AmSurg special issue on #DEI and #leadership @rwjsurgery

https://t.co/xApll9IyIz

[Ankur P. Choubey @AnkurPChoubey]

Delighted to share our work on preemptive renal transplantation and optimal GFR range for improved patient outcomes @rwjsurgery

https://t.co/bXAPtK1oQw

[Ron Barbosa MD FACS @rbarbosa91]

For those that follow my instrument posts, I may now announce there will be an ongoing series in BJS (British Journal of Surgery) called The Instrumentalist.

The first entry in the series is on scalpel handles and blades. Access is free, and is here:

https://t.co/HqsDXUXvDH

[Haejin In @HInMD]

How cool is this ? Craft beer dedicated to celebrate us, by master brewer, surgeon extraordinaire and our Chief Surgical Officer at @RutgersCancer @RichardalexMD. This one dedicated to our very own Dr David August! @rwjsurgery